Dr. Rexford Azumah Babilah, MD

Dr. Babilah practices at Lanham Internal Medicine Associates in Greenbelt, Maryland.

Dr. Babilah's NPI, 1689869968, was assigned on September 11, 2007. Dr. Babilah holds Maryland license D0066658.

Dr. Babilah's primary practice is Lanham Internal Medicine Associates, at 7205 Hanover Pkwy, Greenbelt, MD 20770 in Prince Georges County. The practice phone is (301) 459-1691.

Dr. Babilah's primary practice is Lanham Internal Medicine Associates in Greenbelt, Maryland. Dr. Babilah is also affiliated with Sibley Memorial Hospital. The medical group on file is Lanham Internal Medicine Associates. Dmand AI also links Dr. Babilah to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babilah practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Babilah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Babilah is licensed in Maryland.

CMS data shows 4,320 Medicare services from Dr. Babilah across 21 procedure codes in 2024, for 364 Medicare patients. Medicare paid $313,490 for them. Every service was in an office.

CMS counts 364 Medicare patients who saw Dr. Babilah in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babilah's median patient age at 60, with 55% women.

In 2024, Dr. Babilah wrote 6,363 Medicare Part D claims for 421 patients. 84% of them were for generic drugs. CMS names the drug for 5,443 of them, across 122 drugs with 11 or more claims each, at $929,724 in total drug cost. In 2023, CMS named 4,345 claims across 111 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Babilah for performance year 2024, reported individually. Dr. Babilah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Babilah as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,294 general payments to Dr. Babilah from 78 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $2,893.